A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

Ueno, Hideki; Kosuge, T; Matsuyama, Y; Yamamoto, Junji; Nakao, Akimasa; Egawa, Shinichi; Doi, Ryuichiro; Monden, Morito; Hatori, Takashi; Tanaka, Masao; Shimada, Mitsuo; Kanemitsu, Keiichiro

doi:10.1038/sj.bjc.6605256

Public

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

Published in British Journal of Cancer • Aug 18, 2009

Authors:

Hideki Ueno

T Kosuge

Y Matsuyama

Abstract

BACKGROUND: This multicentre randomised phase III trial was designed to determine whether adjuvant chemotherapy with gemcitabine improves the outcomes of patients with resected pancreatic cancer. METHODS: Eligibility criteria included macroscopically curative resection of invasive ductal carcinoma o...

Subject

Gemcitabine

Medicine

Hazard ratio

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!